forecast
Gray market poses limited threat due to payer system
Despite gray-market peptides from China, traditional pharma will retain most revenue because US drug payment flows through payers rather than direct-to-consumer, so most patients will choose a low-co-pay prescription of the genuine drug over a sketchy vial, making the gray market a limited concern at scale.
forecastpending
Speaker
Jacob KimmelEvidence Quote
“I don't consider that to be a tremendous concern writ large.”
Created: 6/13/2026, 3:28:32 AM
Your notes
Loading notes...